| || |
|Page 1 of 1 || Previous | Next |
| || || |
| | DIABETES IN CONTROL
OCTOBER 19, 2014 [Oral Hypoglycemic Agents] Test Insulin Techniques of New Caregivers
Two years ago, despite use of multiple oral hypoglycemic agents, her glycated hemoglobin (HbA1c) remained at 9.7% (12.9 The patient is an 88-year-old female with a 12-year history of type 2 diabetes. mmol/L) and her home glucose levels were in the mid-200 mg/dL (approximately 11.1 mmol/L) range. Her caretaker was educated on how to administer insulin glargine using a pen device. She was on 10 units of insulin glargine per day.
| || || |
TOPIX [Oral Hypoglycemic Agents] Management of diabetes mellitus in individuals with chronic kidney.
| SATURDAY, FEBRUARY 27, 2016
For this review, a search was performed using several pre-defined keyword combinations and their equivalents: "diabetes kidney disease" and "renal failure" in combination with "diabetes treatment" and "oral
antidiabetic drugs" or "oral hypoglycemic agents MORE >>
THE POOR DIABETIC [Oral Hypoglycemic Agents] Diabetes Technology
| MONDAY, AUGUST 16, 2010
These diabetes technology products represent an enormous $36 billion global market annually, encompassing insulin, blood glucose meters, lancets, test strips, insulin pumps, syringes (and other delivery devices), continuous blood glucose meters and a broad range of anti-diabetic drugs (oral hypoglycemic agents
) and other advancements in diabetes technology. If you are diabetic or hypoglycemic
consult your doctor before taking the Product. MORE >>